Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
ScientificTracks Abstracts: J Clin Exp Pathol
Xinkang Wang, Ph.D., FAHA, is Director Translational Science, Agennix USA, responsible for mechanism of action studies for an immunotherapeutic protein agent, talactoferrin, for the treatment of patients with non-small cell lung cancer. Dr. Wang completed his Ph.D. from the University of Pennsylvania, and has been engaged in drug discovery and development research for 18 years. Dr. Wang?s research has involved in various translational models of diseases for drug discovery and development, including target validation, efficacy, drug safety and translational biomarker discovery. Dr. Wang has published more than 130 peer-reviewed scientific publications and reviews.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals